YPSOMED HLDG/ CH0019396990 /
| 9/29/2023 5:30:55 PM | Chg. +5.00 | Volume | Bid5:45:03 PM | Ask5:45:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 269.50CHF | +1.89% | 20,725 Turnover: 5.6 mill. |
268.00Bid Size: 10 | 268.00Ask Size: 5 | 3.68 bill.CHF | 0.48% | 70.55 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.82 CHF | 105.70 |
| EPS Diluted: | - CHF | 108.74% |
| Revenues per Share: | 36.44 CHF | -0.82% |
| Book Value per Share: | 41.20 CHF | 32.77% |
| Cash Flow per Share: | 9.49 CHF | - |
| Dividend per Share: | 1.30 CHF | 116.67% |
| Total | in mill. | |
| Revenues: | 497.46 CHF | - |
| Net Income: | 51.28 CHF | - |
| Operating Cash Flow: | 129.53 CHF | - |
| Cash and Cash Equivalents: | 25.22 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 70.55 | 50.37 |
| P/S Ratio: | 7.39 | 5.28 |
| P/BV ratio: | 6.54 | 4.67 |
| P/CF Ratio: | 28.40 | 20.27 |
| PEG: | - | 0.46 |
| Earnings Yield: | 1.42% | 1.99% |
| Dividend Yield: | 0.48% | 0.68% |
| Market Capitalization | ||
| Market Capitalization: | 3.68 bill. CHF | 2.63 bill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | - CHF | - CHF |
| Shares Outstanding: | 12.65 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | - |
| Net Profit Margin: | - |
| Return on Equity: | - |
| Return on Assets: | - |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | - |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | - CHF |
| Net Income / Employee: | - CHF |
| Total Assets / Employee: | - CHF |
| * Fiscal Year End: | 3/31/2023 |
| Accounting Standard: | Swiss GAAP FER |
| Currency: | CHF |